Evidence map›Paper›PMID 41103693›Full record

ReviewFrontiers in medicine2025

Navigating the AI tide: challenges, opportunities, and future directions for early-career dermatologists.

Meng Zhang, Ruiqi Chu, Chunmei Liu, Shengni Zhang, Xiangxiang Ren

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Meng ZhangDepartment of Dermatology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Ruiqi ChuDepartment of Dermatology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Chunmei LiuDepartment of Dermatology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Shengni ZhangDepartment of Dermatology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Xiangxiang RenDepartment of General Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) has demonstrated diagnostic accuracy comparable to dermatologists in specific tasks (e.g., 92.5% vs. 86.6% for melanoma detection in multicenter trials), while significantly outperforming early-career physicians (15-20% higher accuracy in meta-analyses). This review synthesizes evidence on AI's transformative impact on dermatology training and practice, addressing critical gaps in ethical frameworks and implementation strategies. We propose a competency-based framework for "AI-augmented dermatology," advocating for curriculum integration of AI literacy modules, standardized human-AI workflows, and proactive engagement in regulatory processes. Early-career dermatologists must leverage AI as a safety net while strengthening irreplaceable skills in complex decision-making and patient communication to lead dermatology's AI-integrated future.

Indexed as

artificial intelligencedermatologic diagnosisearly-career dermatologistsethical and legal challengeshuman-AI collaboration

Identifiers

PMID41103693
PMCPMC12521439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.